CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,623 | -7.8% | 139,134 | +6.4% | 0.00% | 0.0% |
| Q2 2023 | $1,761 | -21.5% | 130,786 | -3.2% | 0.00% | -33.3% |
| Q1 2023 | $2,242 | -16.8% | 135,113 | -6.6% | 0.01% | -14.3% |
| Q4 2022 | $2,695 | -99.8% | 144,644 | +17.6% | 0.01% | +75.0% |
| Q3 2022 | $1,575,000 | +4044.7% | 122,973 | +2166.4% | 0.00% | – |
| Q2 2022 | $38,000 | -20.8% | 5,426 | 0.0% | 0.00% | – |
| Q1 2022 | $48,000 | +29.7% | 5,426 | 0.0% | 0.00% | – |
| Q4 2021 | $37,000 | +27.6% | 5,426 | 0.0% | 0.00% | – |
| Q3 2021 | $29,000 | -6.5% | 5,426 | 0.0% | 0.00% | – |
| Q2 2021 | $31,000 | +24.0% | 5,426 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +38.9% | 5,426 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | +12.5% | 5,426 | 0.0% | 0.00% | – |
| Q3 2020 | $16,000 | -36.0% | 5,426 | 0.0% | 0.00% | – |
| Q2 2020 | $25,000 | +19.0% | 5,426 | 0.0% | 0.00% | – |
| Q1 2020 | $21,000 | +5.0% | 5,426 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | -48.7% | 5,426 | -46.9% | 0.00% | – |
| Q2 2019 | $39,000 | – | 10,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |